Cargando…
Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?
Radiolabelled small molecules for imaging prostate cancer have rapidly emerged over the last few years with gallium-68-labelled prostate-specific-membrane-antigen-11 ((68)Ga-PSMA11), the most widely used. However, the current evidence-based guidelines for management of prostate cancer were establish...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755643/ https://www.ncbi.nlm.nih.gov/pubmed/31565073 http://dx.doi.org/10.1177/1758835919876828 |